Thromboembolic events are known complications of left atrial ablation therapy. We describe a complication which may also lead to systemic thromboembolism that has not been reported so far: the formation of a moving structure attached to the fossa ovalis after an attempted transseptal puncture in a 66-year old patient with symptomatic paroxysmal atrial fibrillation.
JaisP., CauchemezB., MacleL., DaoudE.Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.Circulation2008; 118: 2498–505.
2.
NoheriaA., KumarA., WylieJ.V.Jr., JosephsonM.E.Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review.Arch Intern Med2008; 168: 581–6.
3.
WilberD.J., PapponeC., NeuzilP., DeP.A.Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.JAMA2010; 303: 333–40.
4.
AnneW., TavernierR., DuytschaeverM.Four types of complications in paroxysmal atrial fibrillation ablation.Europace2010; 12: 303–4.
5.
CalkinsH., BrugadaJ., PackerD.L.HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.Heart Rhythm2007; 4: 816–61.
6.
CappatoR., CalkinsH., ChenS.A.Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.Circulation2005; 111: 1100–5.
7.
O'NeillM.D., JaisP., HociniM.Catheter ablation for atrial fibrillation.Circulation2007; 116: 1515–23.
